title: Allogeneic BMT for AML in Zagreb.
authors.affiliation: Department of Medicine, Clinical Hospital Center-Rebro, Zagreb, Yugoslavia.
authors.forename: B
authors.initials: B
authors.lastname: Labar
authors.forename: V
authors.initials: V
authors.lastname: Bogdanić
authors.forename: D
authors.initials: D
authors.lastname: Nemet
authors.forename: M
authors.initials: M
authors.lastname: Mrsić
authors.forename: Z
authors.initials: Z
authors.lastname: Pavletić
authors.forename: S
authors.initials: S
authors.lastname: Zupancić
authors.forename: I
authors.initials: I
authors.lastname: Radman
authors.forename: I
authors.initials: I
authors.lastname: Aurer
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000008:administration & dosage; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000601:surgery*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic
chemical_list: D003524:Cyclosporins; D008727:Methotrexate